Los Angeles, CA -- (SBWire) -- 10/29/2018 --This report focuses on the global Pigmentation Disorders Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pigmentation Disorders Treatment development in United States, Europe and China.
Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, phototherapy, and laser therapy. These therapies are available in hospitals and aesthetic clinics & dermatology centers.
The pigmentation disorder treatment market has been segmented based on treatment, disease indication, end-user, and region. In terms of treatment, the topical drugs segment is estimated to account for a prominent share of the market. An increasing number of patients with pigmentation disorders are visiting dermatologists, and topical drugs are being prescribed to these patients. With an existing unmet need for better treatment armamentarium for severe, recalcitrant patients and an estimated drug-treated population that is expected to double over the next decade, topical drugs is an attractive segment for drug developers. This is expected to fuel commercial interest in the development of tropical drugs.
Request Sample Report Copy@ https://www.qyresearch.com/sample-form/form/669957/global-pigmentation-disorders-treatment-market
Based on disease indication, the vitiligo and melasma segment constituted a major share of the market in 2017. The segment is likely to expand at a significant growth rate as compared to other disease indication segments during the forecast period. Globally, the prevalence of vitiligo and melasma varies. Women are far more likely to be affected by melisma than men, and both sexes are affected equally by vitiligo. In pigmentation, inadequate patient compliance still remains a significant unmet need. This single factor has hindered the ability of patients to achieve maximum treatment benefit, given the therapeutic options currently available, and has resulted in multiple failed treatment attempts.
The Pigmentation Disorder Treatment market has been experiencing steady growth graph since past years. During the 2017-2025 timeline, the global market for Pigmentation Disorder Treatment is expected to reflect a 1.7x increase in the revenue growth. In 2017 the global Pigmentation Disorders market was valued at US$ 5,285 Mn and by the end of the assessment year (2025), it is estimated to touch a value more than US$ 8,912 Mn growing at a value CAGR of 6.75% throughout the period of forecast.
The key players covered in this study
Bayer AG
ALLERGAN
Galderma S.A
SkinCeuticals
Pierre Fabre
EpiPharm AG
RXi Pharmaceuticals Corporation
Obagi Cosmeceuticals LLC
Vivier Pharma
Click here to view Report Page with Table of Contents@ https://www.qyresearch.com/index/detail/669957/global-pigmentation-disorders-treatment-market
Market segment by Type, the product can be split into
Topical Drugs
Microdermabrasion
Chemical Peels
Phototherapy
Laser Therapy
Market segment by Application, split into
Men
Women
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Check discount available on Report before placing Purchase Order@ https://www.qyresearch.com/request-discount/form/669957/global-pigmentation-disorders-treatment-market
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Pigmentation Disorders Treatment Market Is Growing at a CAGR of 6.75% Between 2018 and 2025
QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.